Indiabulls Pharmaceuticals Ltd. was incorporated in July 2016 with an ambition to become a leading provider of healthcare products and services in India and beyond. The Indian healthcare sector is poised for significant growth in the coming decade driven by rising incomes, enhanced medical infrastructure, rise in the prevalence and treatment of chronic diseases and greater health insurance. Specifically, the Indian pharmaceutical market is projected to grow to USD 55 billion by 20201 from a current estimated size of USD 27 billion and this will take the Indian pharmaceutical market in the top 5 global market both in terms of volume and value. The secular growth of the industry is further bolstered by the commitment of the Indian government to increase access for patients and provide benefits for investments in manufacturing and research and development for the manufacturers.